Triple-negative breast cancer (TNBC) is a highly heterogeneous subtype of breast cancer defined by the absence of progesterone and estrogen receptors and the lack of overexpression or amplification of the human epidermal growth factor receptor 2 (HER2) gene. This evidence concerns the gene ERBB2 and breast carcinoma.